Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01NWQ
|
|||
| Former ID |
DNC014784
|
|||
| Drug Name |
N-(4-bromo-2-methylphenyl)-2-naphthamide
|
|||
| Synonyms |
N-(4-bromo-2-methylphenyl)-2-naphthamide; N-(4-bromo-2-methylphenyl)naphthalene-2-carboxamide; 429627-41-8; naphthamide compound 2; AC1LGMF3; ChemBridge compound no. 2; CHEMBL217951; CTK1C8257; BDBM14710; DTXSID40356417; MolPort-002-208-677; ZINC342068; STK222653; AKOS000202277; MCULE-5174732523; AG-670/40742092; 2-Naphthalenecarboxamide, N-(4-bromo-2-methylphenyl)-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H14BrNO
|
|||
| Canonical SMILES |
CC1=C(C=CC(=C1)Br)NC(=O)C2=CC3=CC=CC=C3C=C2
|
|||
| InChI |
1S/C18H14BrNO/c1-12-10-16(19)8-9-17(12)20-18(21)15-7-6-13-4-2-3-5-14(13)11-15/h2-11H,1H3,(H,20,21)
|
|||
| InChIKey |
QDOYRUBXBHREAH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 429627-41-8
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Plasmodium Dihydroorotate dehydrogenase (Malaria DHOdehase) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Pyrimidine metabolism | |||
| Metabolic pathways | ||||
| Pathwhiz Pathway | Pyrimidine Metabolism | |||
| Reactome | Pyrimidine biosynthesis | |||
| WikiPathways | Metabolism of nucleotides | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design and synthesis of potent inhibitors of the malaria parasite dihydroorotate dehydrogenase. J Med Chem. 2007 Jan 25;50(2):186-91. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.